文献速递血液净化与透析

自体动静脉内瘘通畅率与脱离导管时间的国际比较:DOPPS研究

International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
PubMed 文献 · Am J Kidney Dis · 2020-09-21

该前瞻性队列研究基于DOPPS中美国、日本及EUR/ANZ地区466家中心的2,040例血液透析患者新创建的2,191个AVF,比较了AVF通畅率和脱离导管依赖时间。日本因AVF成功使用率更高而原发和累积通畅率更优,但累积功能性通畅率各地区相似;EUR/ANZ和美国患者导管依赖时间更长,AVF创建后6个月内未使用者后续6个月死亡率高53%。

要点

  • 日本AVF原发和累积通畅率优于EUR/ANZ和美国,但累积功能性通畅率相似。
  • AVF创建后未成功使用时,EUR/ANZ和美国近70%患者8个月后仍依赖导管。
  • AVF创建后6个月内未使用动静脉通路与后续6个月死亡率高53%相关。

核心结论

  • 日本AVF原发和累积通畅率更优,归因于更高的AVF成功使用率,而累积功能性通畅率各地区相似。
  • 新创建AVF未成功使用与长期导管暴露和死亡风险升高相关。

研究设计与样本

  • 前瞻性队列研究,纳入2009至2015年DOPPS中美国、日本及EUR/ANZ地区466家随机选取中心内2,040例血液透析患者新创建的2,191个AVF。

主要发现

  • 各地区患者平均年龄61至66岁,男性占比55%至66%,中位透析龄0.3至3.2年。
  • 日本、EUR/ANZ和美国分别有84%、54%和32%的AVF创建于前臂。
  • AVF创建后未成功使用时,EUR/ANZ和美国近70%患者8个月后仍依赖导管。
  • AVF创建后6个月内未使用动静脉通路与后续6个月死亡率高53%相关。

临床怎么用

  • 应重新评估优化长期通路规划和可实现AVF结局的实践,尤其关注AVF成熟。
  • 需为每位患者选择最佳通路类型,并建立AVF成熟失败时的有效临床路径。

局限性

  • 存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Optimizing vascular access use is crucial for long-term hemodialysis patient care. Because vascular access use varies internationally, we examined international differences in arteriovenous fistula (AVF) patency and time to becoming catheter-free for patients receiving a new AVF. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 2,191 AVFs newly created in 2,040 hemodialysis patients in 2009 to 2015 at 466 randomly selected facilities in the Dialysis Outcomes and Practice Patterns Study (DOPPS) from the United States, Japan, and EUR/ANZ (Belgium, France, Germany, Italy, Spain, Sweden, United Kingdom, Australia, and New Zealand). PREDICTORS: Demographics, comorbid conditions, dialysis vintage, body mass index, AVF location, and country/region. OUTCOMES: Primary/cumulative AVF patency (from creation), primary/cumulative functional patency (from first use), catheter dependence duration, and mortality. ANALYTICAL APPROACH: Outcomes estimated using Cox regression. RESULTS: Across regions, mean patient age ranged from 61 to 66 years, with male preponderance ranging from 55% to 66%, median dialysis vintage of 0.3 to 3.2 years, with 84%, 54%, and 32% of AVFs created in the forearm in Japan, EUR/ANZ, and United States, respectively. Japan displayed superior primary and cumulative patencies due to higher successful AVF use, whereas cumulative functional patency was similar across regions. AVF patency associations with age and other patient characteristics were weak or varied considerably between regions. Catheter-dependence following AVF creation was much longer in EUR/ANZ and US patients, with nearly 70% remaining catheter dependent 8 months after AVF creation when AVFs were not successfully used. Not using an arteriovenous access within 6 months of AVF creation was related to 53% higher mortality in the subsequent 6 months. LIMITATIONS: Residual confounding. CONCLUSIONS: Our findings highlight the need to reevaluate practices for optimizing long-term access planning and achievable AVF outcomes, especially AVF maturation. New AVFs that are not successfully used are associated with long-term catheter exposure and elevated mortality risk. These findings highlight the importance of selecting the best access type for each patient and developing effective clinical pathways for when AVFs fail to mature successfully.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Pisoni RL, Zepel L, Zhao J, et al. International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2020. PMID: 32971192. doi:10.1053/j.ajkd.2020.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。